Search tips
Search criteria 


Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2011; 6(5): e14812.
Published online 2011 May 19. doi:  10.1371/journal.pone.0014812
PMCID: PMC3098227

Partial Netrin-1 Deficiency Aggravates Acute Kidney Injury

Ludovic Tailleux, Editor


The netrin family of secreted proteins provides migrational cues in the developing central nervous system. Recently, netrins have also been shown to regulate diverse processes beyond their functions in the brain, incluing the ochrestration of inflammatory events. Particularly netrin-1 has been implicated in dampening hypoxia-induced inflammation. Here, we hypothesized an anti-inflammatory role of endogenous netrin-1 in acute kidney injury (AKI). As homozygous deletion of netrin-1 is lethal, we studied mice with partial netrin-1 deletion (Ntn-1+/− mice) as a genetic model. In fact, Ntn-1+/− mice showed attenuated Ntn-1 levels at baseline and following ischemic AKI. Functional studies of AKI induced by 30 min of renal ischemia and reperfusion revealed enhanced kidney dysfunction in Ntn-1+/− mice as assessed by measurements of glomerular filtration, urine flow rate, urine electrolytes, serum creatinine and creatinine clearance. Consistent with these findings, histological studies indicated a more severe degree kidney injury. Similarly, elevations of renal and systemic inflammatory markers were enhanced in mice with partial netrin-1 deficiency. Finally, treatment of Ntn-1+/− mice with exogenous netrin-1 restored a normal phenotype during AKI. Taking together, these studies implicate endogenous netrin-1 in attenuating renal inflammation during AKI.


Acute kidney injury (AKI) is defined a decrease in the glomerular filtration rate (GFR), occurring over a period of minutes to days. AKI is frequently caused by renal ischemia, and represents an important cause of morbidity and mortality of hospitalized patients [1], [2], [3]. A recent study revealed that only a mild increase in the serum creatinine level (0.3 mg/dl) is associated with a 70% greater risk of death than in patients without any increase [2], [3]. Along these lines, surgical procedures requiring cross-clamping of the aorta and renal vessels are associated with a rate of AKI of up to 30% [4]. Similarly, acute renal failure after cardiac surgery occurs in up to 10% of patients under normal circumstances and is associated with dramatic increases in mortality [5]. Moreover, patients with sepsis frequently go on to develop AKI and the combination of moderate sepsis and AKI is associated with a 70% rate of mortality. Therapeutic approaches are very limited and the majority of interventional trials in AKI have failed in humans [6]. Therefore, additional therapeutic modalities to prevent or treat AKI presently represent an area of intense investigation [7].

Named after the Sanskrit word netr, which means ‘one who guides’, the netrin family of secreted proteins provides migrational cues in the developing central nervous system. More recently, netrins have been shown to regulate diverse processes (such as cell adhesion, motility, proliferation, differentiation and, ultimately, cell survival) in a number of non-neuronal tissues [8]. The ability of the guidance molecule netrin-1 (Ntn-1) to repulse or abolish attraction of neuronal cells makes it an attractive candidate for the regulation of inflammatory cell migration. In fact, previous studies have shown that Ntn-1 is involved in the orchestration of inflammatory responses in vitro or in vivo [9], [10]. Particularly, netrin-1 has been implicated in regulating inflammatory events during conditions of tissue hypoxia [9]. Given that mucosal surfaces are particularly prone to hypoxia-elicited inflammation, a recent study sought to determine the function of netrin-1 in hypoxia-induced inflammation [9]. The authors observed hypoxia-inducible factor 1alpha (HIF-1α)-dependent induction of expression of the gene encoding Ntn1 in hypoxic epithelia. Neutrophil transepithelial migration studies showed that by engaging A2B adenosine receptor (A2BAR) on neutrophils, netrin-1 attenuated neutrophil transmigration. Another study demonstrated that endothelial netrin-1 interacts with inflammatory cells and is capable of attenuating inflammation by potent inhibition of myeloid cell migration [10]. Taken together, these studies indicate that netrin-1 attenuates organ injury by hypoxia or inflammation [9].

Recent studies in the kidney showed that exogenous netrin-1 treatment in mice or renal ischemia in mice overexpressing renal netrin-1 attenuated kidney injury following ischemia [11], [12]. The same authors showed that UNC5B receptors on leucocytes attenuate kidney injury due to ischemia [13]. Furthermore they showed that urinary netrin-1 excretion is increased in patients following acute renal failure compared to urine from healthy controls suggesting netrin-1 as an early biomarker for acute renal failure [14]. However, studies in gene-targeted mice for netrin-1 have not been performed.

Due to the fact that AKI is characterized by an acute inflammatory event in the context of tissue hypoxia, we hypothesized a role of endogenous netrin-1 in dampening ischemia-driven inflammation and kidney dysfunction during AKI. We were particularly interested in identifying the role of endogenous netrin-1 in this response – as the adult kidney was previously shown to be the single organ with the highest expression of netrin-1 (even higher than the brain) [10]. Based on previous studies showing that netrin-1 is induced during conditions of limited oxygen availability (hypoxia), and dampens hypoxia-induced inflammation [9], we hypothesized a role for endogenous netrin-1 in dampening renal failure after AKI. In fact, studies of in gene-targeted mice for netrin-1 confirmed our hypothesis and indicate a protective role of endogenous netrin-1 in AKI.

Material and Methods

In vivo model of AKI

The animal protocol was approved by the Institutional Animal Care and Use Committee of the University of Colorado Denver, and is in accordance with the National Institutes of Health guidelines for use of live animals. Previously described Ntn-1+/− mice or Ntn-1+/+ mice littermate controls matched in age, gender, and weight were used [15].

Mice were anaesthetized using 50 mg/kg i.p. pentobarbital and underwent right nephrectomy followed by left renal artery ischemia for 30 minutes by using a hanging weight system, as previously described [16], [17], [18], [19]. Plasma creatinine and urine creatinine and potassium were measured 24 hours following renal ischemia by the hospital laboratory and kidneys were harvested and stored at −80°C until further analysis. Inulin clearance was measured 60 minutes following renal ischemia as described previously [17]. Briefly, the right jugular vein was cannulated for continuous infusion. Next, 0.75% FITC-inulin was added to the infusion for determination of glomerular filtration rate (GFR). Blood samples were taken via retroorbital puncture. A catheter was placed in the urinary bladder for timed urine collection. Three urine collection periods were performed with blood collection in the middle of the period. FITC-inulin concentrations in plasma and urine samples were measured.

Cell culture and hypoxia exposure

Human renal epithelial cells (HK-2) were exposed to normobaric hypoxia (1% O2, 99%N2) in a hypoxic chamber (hypoxic glove box, COY Laboratory Products INC. Michigan, USA) over indicated time periods.

Transcriptional Studies

We used real-time RT-PCR (iCycler; Bio-Rad Laboratories Inc.) to examine Ntn-1, IL-6, TNF-α and IL-10 expression in renal tissue as previously described [9], [13]. Primer sets (sense sequence, antisense sequence, and transcript size, respectively) for the following genes were: netrin-1 (5′- CTCACAGCAATGTCAACAGC -3′, 5′- GCAGGAAGCAGTCACAGAAT -3′, 191 bp); IL6 (5′ - CGG AGA GGA GAC TTC ACA GA -3′, 5′ - CCA GTT TGG TAG CAT CCA TC -3′, 218 bp); TNF-α (5′- CCCACTCTGACCCCTTTACT -3′, 5′- TTTGAGTCCTTGATGGTGGT -3′, 201 bp); IL-10 (5′-CCCAAGTAACCCTTAAAGTCCTTGC, 5′-ATGCTGCCTGCTCTTACTGACTG-3′, 200 bp). Murine ß-actin mRNA (5′- CTAGGCACCAGGGTGTGAT -3′, 5′- TGCCAGATCTTCTTCATGTC -3′) was amplified in identical reactions to control for the amount of starting template.

Renal histology

Kidneys were excised and harvested 24 hours following 30 minutes of ischemia. Paraffin-embedded sections (3 µm) were stained with hematoxylin and eosin or rat anti-mouse neutrophil MCA771G antibody (Abd Serotec, NC, USA) to assess neutrophil accumulation in the kidneys [17].

Human and mouse protein analysis

Renal tissues and renal epithelial cells (HK-2 cells) were blotted using polyclonal rabbit anti-netrin-1 (Calbiochem Laboratories) and polyclonal goat anti-netrin-1 (Santa Cruz), respectively [9].


Immunohistochemistry for NTN-1 on 3-µm-thick kidney sections was performed using formalin-fixed, paraffin-embedded tissue and sections that were stained with polyclonal rabbit anti-mouse netrin-1 (Calbiochem Laboratories) [9].

Netrin-1 ELISA

Netrin-1 in renal tissue and urine was measured using a commercially available ELISA kit (Hoelzel Diagnostika, Germany).

Statistic analysis

Data are presented as mean ± SD from four to six animals per condition. We performed statistical analysis using the Student t test (two sided, <0.05). Renal injury scores were analyzed with the Kruskal-Wallis rank test and are given as median ± range. A value of p<0.05 was considered statistically significant.


Renal netrin-1 expression in Ntn-1+/− mice

To study the role of endogenous netrin-1 in AKI, we utilized previously described mice with genetic deletion of netrin-1 [9], [15]. Homozygote mice gene-targeted for netrin-1 are not viable, and die shortly after birth [15]. Therefore, we examined mice with partial netrin-deficiency (Ntn-1+/− mice) [9]. Initial characterization of renal netrin-1 expression in Ntn-1+/− mice revealed significant reduction of netrin-1 transcript and protein levels at baseline (Figure 1A–C). As next step, we induced ischemic AKI in wild-type mice (30 min of renal ischemia followed by 2 h of reperfusion, Figure 1 D, E) and observed robust increases of renal netrin-1 levels. In contrast, renal netrin-1 levels in Ntn-1+/− mice exposed to AKI remained approximately at wild-type baseline levels. Immunohistochemistry for renal netrin-1 indicated dominant netrin-1 expression in proximal tubular cells, in conjunction with increased netrin-1 levels following renal ischemia. In contrast, renal netrin-1 staining at baseline or following renal ischemia was attenuated in Ntn-1+/− mice. To further define netrin-1 expression we measured netrin-1 in renal tissue, urine and serum via ELISA. Interestingly we could show a tremendous increase of netrin-1 in renal tissue and urine following ischemia in wild-type control mice compared to Ntn-1+/− mice, whereas serum concentrations were not detectable assuming that netrin-1 expression occurs mainly in renal epithelial cells (Figure 2E, F). Similarly, renal epithelial cells (HK-2 cells) showed robust expression of netrin-1 in conjunction with netrin-1 induction following exposure to ambient hypoxia (1% oxygen over 0–24 h, Figure 3A and B). Taken together, these studies indicate robust netrin-1 expression predominantly in renal epithelia, and suggest that mice with partial netrin-1 deficiency can be used as a model to study endogenous netrin-1 during ischemia-induced AKI.

Figure 1
Renal netrin-1 expression in wild-type mice (Ntn1+/+) or mice with partial netrin-1 deficiency (Ntn1+/−).
Figure 2
Immunohistochemical localization of renal netrin-1 and netrin-1 tissue content and urine concentration following ischemia in vivo.
Figure 3
In vitro expression of netrin-1 in HK-2 cells.

AKI is aggravated in Ntn-1+/− mice

After having characterized renal netrin-1 expression at baseline or following AKI, we next pursued functional studies of AKI in Ntn-1+/− mice. For this purpose, we utilized a previously described model of ischemia induced AKI where isolated renal artery occlusion is achieved via a hanging weight system, thereby minimizing surgical trauma [16], [17], [18], [19]. In short, we performed a unilateral nephrectomy, followed by selective left renal artery occlusion via a hanging weight-system in the remaining kidney to induce AKI [16]. Following 30 min of renal ischemia and 1 hour of reperfusion, we measured glomerular filtration rate by infusion of FITC-labeled inulin via a jugular vein infusion catheter. These studies revealed a significantly enhanced decrease in renal GFR following AKI induction in Ntn-1+/− mice as compared to littermate controls matched in age, gender and weight (Figure 4A). Similarly, measurements of urinary flow rate, potassium excretion, serum creatinine and creatinine clearance measured 24 hours following renal ischemia, indicate a more severe degree of AKI in mice with partial netrin-1 deficiency (Figure 4B–E). Moreover, studies of renal histology demonstrate more severe acute tubular necrosis—obvious from the loss of tubular cell nuclei in the cortex and outer medulla with destruction of the proximal tubular brush border. In addition, hyaline cast formation, intraluminal necrotic cellular debris, and casts containing brush border blebs were more predominant in Ntn-1+/− mice exposed to renal ischemia (Figure 5A–D). This was confirmed utilizing a histologic score for the severity of AKI (Figure 5E). Together, these studies indicate that ischemia-induced AKI is more severe in Ntn-1+/− mice.

Figure 4
Renal function in mice with partial deficiency for netrin-1 (Ntn1+/−) exposed to ischemic AKI.
Figure 5
Histological tissue insure induced by AKI in mice with partial netrin-1 deficiency (Ntn1+/−) or control mice (Ntn1+/+).

AKI induced renal inflammation is enhanced following partial Ntn-1+/− deficiency

Based on previous studies indicating that netrin-1 signaling dampens acute inflammatory events induced by hypoxia [9], we went on to assess the role of endogenous netrin-1 in AKI-induced renal inflammation. Here, histological staining, or measurements of renal myeloperoxidase indicate that neutrophil accumulation following AKI is enhanced in Ntn-1+/− mice (Figure 6A–E). Moreover, AKI-induced elevations of renal inflammatory markers including TNF-α and IL-6 were enhanced whereas the anti-inflammatory cytokine IL -10 was reduced in mice with partial netrin-1 deficiency (Figure 6F–H). Together, these studies suggest that endogenous netrin-1 signaling represents an endogenous feedback loop to dampen AKI-induced inflammation of the kidneys.

Figure 6
Renal inflammatory changes in Ntn1+/− mice following ischemia.

Reconstitution of Ntn-1+/− mice during AKI

As proof of principle for the assertion that netrin-1 plays an important role in the regulation of renal injury and kidney inflammation during AKI, we reconstituted Ntn-1+/− mice with exogenous netrin-1 (5 µg/mouse I.V. 30 min prior to induction of AKI) [9]. We have chosen this netrin-1 dose based on previous studies testing different netrin-1 doses (0.5, 1, 5, 10 µg/mouse I.V.) showing the strongest renal protection from ischemia injury with 5 µg/mouse. In fact, these studies revealed that reconstitution with exogenous netrin-1 restored a wild-type phenotype for AKI-induced changes of GFR or renal inflammation following AKI in Ntn-1+/− mice (Figure 7A and B). Taken together, these studies provide strong evidence that netrin-1 signaling is a critical control point for kidney inflammation and tissue injury following AKI.

Figure 7
Reconstitution of Ntn1+/− mice with exogenous netrin-1.


Tissue hypoxia during AKI results in severe kidney inflammation, including inflammatory cell accumulation, cytokine release, and inflammation-associated organ dysfunction. Based on recent studies suggesting a role of the neuronal guidance molecule netrin-1 in dampening hypoxia-elicited inflammation [9], we examined the role of netrin-1 in AKI. Utilizing mice with partial netrin-1 deficiency (Ntn-1+/− mice) we found that these mice are more prone to AKI-induced kidney dysfunction and renal inflammation. Moreover, reconstitution of Ntn-1+/− mice with exogenous netrin-1 retreatment resuscitated their phenotype. Taken together, these studies provide the first genetic in vivo evidence for a critical role of endogenous netrin-1 in attenuating AKI-driven renal dysfunction and inflammation.

At present, the signaling pathways involving renal protection through netrin-1 remain unclear. Previous studies have indicated that endogenous netrin-1 is released into the urine, and can serve as an early biomarker of AKI [14], [20]. Other studies suggest that netrin-1 signaling via activation of the UNC5B receptor protects the kidneys from ischemia [11], [21]. Moreover, a very elegant study utilizing a genetic model of netrin-1 overexpression demonstrates that netrin-1 signaling protects the kidneys from ischemia reperfusion injury by suppressing tubular epithelial apoptosis [12]. Finally, another study suggests that anti-inflammatory signaling events of netrin-1 involve the A2B adenosine receptor (A2BAR), particularly during conditions of hypoxia-elicited inflammation [9]. While the mechanisms of how netrin-1 interacts with the A2BAR remain unclear, this study demonstrates that netrin-1 signaling events enhance adenosine-dependent tissue protection from hypoxia [9], [17], [22], [23], [24], [25]. This assumption would be consistent with other studies on the role of the A2BAR in myocardial ischemia [23], [25], vascular leakage [26], [27], intestinal inflammation [24], [28], [29], or acute lung injury [22], [30], where hypoxia-elicited induction of the A2BAR [31] attenuates organ inflammation and dysfunction. In fact, hypoxia has been shown to drive a coordinated adenosine response of different tissues [32], [33], [34], [35], including increased adenosine production [36], [37], [38], [39], [40], [41], [42], [43], [44], induction of the A2BAR [45], attenuated adenosine uptake [46], [47], [48] and metabolism [49], thereby enhancing anti-inflammatory and protective tissue responses during acute hypoxia [50], [51], [52]. In fact, extracellular adenosine signaling has been strongly implicated as a therapeutic in different models of kidney injury, including AKI [17], [18], [19], [23], [53], [54], [55].

Taken together, the present results identify endogenous netrin-1 as an endogenous anti-inflammatory during AKI. Future studies will have to determine the exact contribution of different tissues, e.g. by utilizing tissue-specific approaches of netrin-1 deletion, or its receptor in the kidneys. Moreover, a more mechanistic understanding of netrin-1 signaling events would set the stage for targeting netrin-1 in the treatment of patients suffering from AKI, e.g. by designing specific netrin-1 mimetic peptides. Finally, future challenges require to address the consequences of acute versus a more chronic activation of netrin-1-dependent signaling pathways. For instance, previous studies have implicated chronic activation of adenosine signaling pathways in promoting a chronic form of disease and tissue fibrosis [56], [57], [58], [59], whereas adenosine signaling events in an acute setting dampen inflammatory responses and contribute to the resolution of injury [24], [29], [30], [35], [39], [46], [51], [60], [61].


Competing Interests: The authors have declared that no competing interests exist.

Funding: The present studies were supported by United States National Institutes of Health grant R01-HL0921, R01-DK083385 and R01HL098294 and Foundation for Anesthesia Education and Research (FAER) Grants to HKE, an American Society of Nephrology Medical Student Scholar grant and FAER grant to JDB, JHD and AB, and a DFG (Deutsche Forschungsgemeinschaft) Research Fellowship Grant (GR2121/1-1) to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351:159–169. [PubMed]
2. Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med. 2007;357:797–805. [PubMed]
3. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365–3370. [PubMed]
4. Gelman S. The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology. 1995;82:1026–1060. [PubMed]
5. Mehta RL. Acute renal failure and cardiac surgery: marching in place or moving ahead? J Am Soc Nephrol. 2005;16:12–14. [PubMed]
6. Bove T, Landoni G, Calabro MG, Aletti G, Marino G, et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation. 2005;111:3230–3235. [PubMed]
7. Leonard MO, Cottell DC, Godson C, Brady HR, Taylor CT. The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia. J Biol Chem. 2003;278:40296–40304. [PubMed]
8. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol. 2003;4:285–294. [PubMed]
9. Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, et al. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol. 2009;10:195–202. [PubMed]
10. Ly NP, Komatsuzaki K, Fraser IP, Tseng AA, Prodhan P, et al. Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc Natl Acad Sci U S A. 2005;102:14729–14734. [PubMed]
11. Wang W, Brian Reeves W, Ramesh G. Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney. Am J Physiol Renal Physiol. 2008;294:F739–747. [PubMed]
12. Wang W, Reeves WB, Pays L, Mehlen P, Ramesh G. Netrin-1 overexpression protects kidney from ischemia reperfusion injury by suppressing apoptosis. Am J Pathol. 2009;175:1010–1018. [PubMed]
13. Tadagavadi RK, Wang W, Ramesh G. Netrin-1 regulates Th1/Th2/Th17 cytokine production and inflammation through UNC5B receptor and protects kidney against ischemia-reperfusion injury. J Immunol. 2010;185:3750–3758. [PubMed]
14. Brian Reeves W, Kwon O, Ramesh G. Netrin-1 and kidney injury. II. Netrin-1 is an early biomarker of acute kidney injury. Am J Physiol Renal Physiol. 2008;294:F731–738. [PubMed]
15. Serafini T, Colamarino SA, Leonardo ED, Wang H, Beddington R, et al. Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system. Cell. 1996;87:1001–1014. [PubMed]
16. Grenz A, Eckle T, Zhang H, Huang DY, Wehrmann M, et al. Use of a hanging-weight system for isolated renal artery occlusion during ischemic preconditioning in mice. Am J Physiol Renal Physiol. 2007;292:F475–F485. [PubMed]
17. Grenz A, Osswald H, Eckle T, Yang D, Zhang H, et al. The Reno-Vascular A2B Adenosine Receptor Protects the Kidney from Ischemia. PLoS Medicine. 2008;5:e137. [PMC free article] [PubMed]
18. Grenz A, Zhang H, Eckle T, Mittelbronn M, Wehrmann M, et al. Protective role of ecto-5′-nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol. 2007;18:833–845. [PubMed]
19. Grenz A, Zhang H, Hermes M, Eckle T, Klingel K, et al. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J. 2007;21:2863–2873. [PubMed]
20. Ramesh G, Krawczeski CD, Woo JG, Wang Y, Devarajan P. Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol. 5:395–401. [PubMed]
21. Wang W, Reeves WB, Ramesh G. Netrin-1 increases proliferation and migration of renal proximal tubular epithelial cells via the UNC5B receptor. Am J Physiol Renal Physiol. 2009;296:F723–729. [PubMed]
22. Eckle T, Grenz A, Laucher S, Eltzschig HK. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest. 2008;118:3301–3315. [PMC free article] [PubMed]
23. Eltzschig HK. Adenosine: an old drug newly discovered. Anesthesiology. 2009;111:904–915. [PMC free article] [PubMed]
24. Hart ML, Jacobi B, Schittenhelm J, Henn M, Eltzschig HK. Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol. 2009;182:3965–3968. [PubMed]
25. Eckle T, Krahn T, Grenz A, Kohler D, Mittelbronn M, et al. Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation. 2007;115:1581–1590. [PubMed]
26. Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, et al. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood. 2008;111:2024–2035. [PubMed]
27. Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R, et al. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med. 2004;200:1395–1405. [PMC free article] [PubMed]
28. Eltzschig HK, Rivera-Nieves J, Colgan SP. Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation. Expert Opin Ther Targets. 2009;13:1267–1277. [PubMed]
29. Frick JS, MacManus CF, Scully M, Glover LE, Eltzschig HK, et al. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J Immunol. 2009;182:4957–4964. [PMC free article] [PubMed]
30. Schingnitz U, Hartmann K, Macmanus CF, Eckle T, Zug S, et al. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol. 2010;184:5271–5279. [PMC free article] [PubMed]
31. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP. HIF-dependent induction of adenosine A2B receptor in hypoxia. Faseb J. 2006;20:2242–2250. [PubMed]
32. Sitkovsky M, Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol. 2005;5:712–721. [PubMed]
33. Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annual Review of Immunology. 2004;22:657–682. [PubMed]
34. Thiel M, Chouker A, Ohta A, Jackson E, Caldwell C, et al. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 2005;3:e174. [PMC free article] [PubMed]
35. Eltzschig HK, Ibla JC, Furuta GT, Leonard MO, Jacobson KA, et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med. 2003;198:783–796. [PMC free article] [PubMed]
36. Eltzschig HK, Kohler D, Eckle T, Kong T, Robson SC, et al. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood. 2009;113:224–232. [PubMed]
37. Kohler D, Eckle T, Faigle M, Grenz A, Mittelbronn M, et al. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation. 2007;116:1784–1794. [PubMed]
38. Reutershan J, Vollmer I, Stark S, Wagner R, Ngamsri KC, et al. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J. 2009;23:473–482. [PubMed]
39. Hart ML, Gorzolla IC, Schittenhelm J, Robson SC, Eltzschig HK. SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J Immunol. 2010;184:4017–4024. [PMC free article] [PubMed]
40. Hart ML, Henn M, Kohler D, Kloor D, Mittelbronn M, et al. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J. 2008;22:2784–2797. [PubMed]
41. Hart ML, Much C, Gorzolla IC, Schittenhelm J, Kloor D, et al. Extracellular adenosine production by ecto-5′-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology. 2008;135:1739–1750 e1733. [PubMed]
42. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med. 1999;5:1010–1017. [PubMed]
43. Guckelberger O, Sun XF, Sevigny J, Imai M, Kaczmarek E, et al. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury. Thromb Haemost. 2004;91:576–586. [PubMed]
44. Dwyer KM, Robson SC, Nandurkar HH, Campbell DJ, Gock H, et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest. 2004;113:1440–1446. [PMC free article] [PubMed]
45. Eckle T, Kohler D, Lehmann R, El Kasmi KC, Eltzschig HK. Hypoxia-Inducible Factor-1 Is Central to Cardioprotection: A New Paradigm for Ischemic Preconditioning. Circulation. 2008;118:166–175. [PubMed]
46. Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, et al. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med. 2005;202:1493–1505. [PMC free article] [PubMed]
47. Loffler M, Morote-Garcia JC, Eltzschig SA, Coe IR, Eltzschig HK. Physiological roles of vascular nucleoside transporters. Arterioscler Thromb Vasc Biol. 2007;27:1004–1013. [PubMed]
48. Morote-Garcia JC, Rosenberger P, Nivillac NM, Coe IR, Eltzschig HK. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology. 2009;136:607–618. [PubMed]
49. Morote-Garcia JC, Rosenberger P, Kuhlicke J, Eltzschig HK. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood. 2008;111:5571–5580. [PubMed]
50. Eltzschig HK, Eckle T, Mager A, Kuper N, Karcher C, et al. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res. 2006;99:1100–1108. [PubMed]
51. Eltzschig HK, Thompson LF, Karhausen J, Cotta RJ, Ibla JC, et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood. 2004;104:3986–3992. [PubMed]
52. Fredholm BB. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 2007;14:1315–1323. [PubMed]
53. Lu B, Rajakumar SV, Robson SC, Lee EK, Crikis S, et al. The impact of purinergic signaling on renal ischemia-reperfusion injury. Transplantation. 2008;86:1707–1712. [PubMed]
54. Park SW, Chen SW, Kim M, Brown KM, D'Agati VD, et al. Protection against acute kidney injury via A1 adenosine receptor-mediated Akt activation reduces liver injury after liver ischemia and reperfusion in mice. J Pharmacol Exp Ther 2010 [PubMed]
55. Kim M, Chen SW, Park SW, D'Agati VD, Yang J, et al. Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kidney Int. 2009;75:809–823. [PMC free article] [PubMed]
56. Blackburn MR, Vance CO, Morschl E, Wilson CN. Adenosine receptors and inflammation. Handb Exp Pharmacol. 2009:215–269. [PubMed]
57. Mi T, Abbasi S, Zhang H, Uray K, Chunn JL, et al. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest. 2008;118:1491–1501. [PMC free article] [PubMed]
58. Sun CX, Zhong H, Mohsenin A, Morschl E, Chunn JL, et al. Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest. 2006;116:2173–2182. [PMC free article] [PubMed]
59. Wen J, Jiang X, Dai Y, Zhang Y, Tang Y, et al. Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling. FASEB J. 24:740–749. [PubMed]
60. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, et al. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest. 2002;110:993–1002. [PMC free article] [PubMed]
61. Eltzschig HK, Faigle M, Knapp S, Karhausen J, Ibla J, et al. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood. 2006;108:1602–1610. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science